台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.0
  • 漲跌
    ▲0.2
  • 漲幅
    +0.33%
  • 成交量
    11
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智基 (6294)籌碼相關-元大-六合 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-六合 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1400.00359.0059.00-391-3.28%
2025/01/13159.2000.0059.401911.09%
2025/01/10159.8000.0059.601911.12%
2024/12/2400.00160.6062.00-190-1.11%
2024/12/18061.0000.0061.100910.02%
2024/12/16062.6800.0062.100900.04%
2024/12/13063.0000.0063.100890.02%
2024/12/12064.0000.0063.800890.02%
2024/12/09166.9000.0066.401941.06%
2024/11/26165.5000.0065.301991.01%
2024/11/2100.00163.3063.30-194-1.06%
2024/11/200.167.3800.0064.400.1910.07%
2024/11/1900.00168.8069.30-188-1.12%
2024/11/14071.60170.5069.70-1102-0.94%
2024/11/13078.502.177.4177.40-2.197-2.11%
2024/11/12186.1000.0086.001901.14%
2024/11/08197.0000.0096.6011030.97%
2024/11/050.197.5000.0097.500.11320.07%
2024/10/2900.00096.7096.400135-0.01%
2024/10/28096.8000.0096.4001350.01%
2024/10/23096.9000.0096.5001360.01%
2024/10/11097.60197.1097.40-1137-0.72%
2024/10/09097.4000.0097.4001380.01%
2024/09/18096.8000.0096.2001390.01%
2024/09/12196.6000.0096.8011400.71%
2024/09/021100.5000.00100.5011390.72%
2024/08/292100.5000.00101.0021381.44%
2024/08/211103.5000.00102.0011350.74%
2024/08/202105.0000.00104.5021331.50%
2024/08/191106.502107.25106.00-1130-0.77%
2024/08/151104.0000.00102.5011140.87%
2024/08/121102.5000.00102.501991.01%
2024/08/090100.0000.00100.500930.01%
2024/08/0700.000.2107.50108.00-0.297-0.15%
2024/08/06198.5000.00100.001901.12%
2024/06/2100.001100.50100.50-1140-0.71%
2024/06/2000.001100.50101.00-1142-0.70%
2024/06/180101.0000.00101.0001450.01%
2024/06/140101.0000.00100.5001480.01%
2024/06/130101.0000.00100.5001520.01%
2024/06/120101.0000.00101.0001550.01%
2024/06/060102.5000.00102.5001570.01%
2024/05/280103.0000.00102.5001580.01%
2024/05/270103.0000.00102.5001580.01%
2024/05/230.1103.0000.00102.500.11570.03%
2024/05/161106.0000.00107.0011500.67%
2024/05/141101.5200.00102.0011440.72%
2024/05/130.2107.000107.00107.000.21270.12%
2024/04/220115.5000.00116.0001140.01%
2024/04/190115.0000.00116.0001130.01%
2024/04/1700.000116.50117.000111-0.01%
2024/04/160115.3300.00114.0001110.02%
2024/04/150117.000117.00117.000107-0.02%
2024/04/120118.0000.00118.0001040.02%
2024/04/111119.0000.00119.5011010.98%
2024/04/080123.500.5124.00123.50-0.573-0.68%
2024/03/2700.000122.50122.00066-0.03%
2024/03/2500.000.3124.00124.00-0.362-0.45%
2024/03/2000.000.1122.85121.50-0.156-0.24%
2024/03/1900.001121.02123.00-155-1.86%
2024/03/081113.0000.00113.501342.87%
2024/03/072114.5000.00114.002345.81%
2024/02/2300.000.1112.00112.50-0.132-0.26%
2024/02/2200.000112.50112.00032-0.05%
2024/02/1900.000112.00113.00031-0.08%
2024/02/0500.000.1112.03112.50-0.131-0.30%
2024/02/0200.000113.00112.00031-0.02%
2024/01/310.5111.0000.00111.500.5311.66%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音